SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001279569-07-001729
Filing Date
2007-11-30
Accepted
2007-11-30 15:19:22
Documents
8
Period of Report
2007-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F lorus20f18566.htm 20-F 2922116
2 STOCK OPTION PLANS ex41.htm EX-4.1 375170
3 CEO CERTIFICATE CDN ex121.htm EX-12.1 14490
4 CFO CERTIFICATE CDN ex122.htm EX-12.2 14663
5 CEO CERTIFICATE US ex131.htm EX-13.1 5985
6 CFO CERTIFICATE US ex132.htm EX-13.2 5915
7 GRAPHIC loruslogo.jpg GRAPHIC 3294
8 CHART chart.jpg GRAPHIC 38877
  Complete submission text file 0001279569-07-001729.txt   3398351
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-32001 | Film No.: 071277696
SIC: 2836 Biological Products, (No Diagnostic Substances)